Search

everythinglearnresearchcommunity

for

Search:↓

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Pix Liquida helped a man recover from patchy hair loss.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Certain hair and scalp features can predict the severity of alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Bempikibart may help regrow hair in people with alopecia areata.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.